Boston Scientific Corporation to Pay $30 Million Over Defective Heart Devices: DOJ
Published: Oct 18, 2013
Boston Scientific Corp agreed to pay $30 million to settle allegations that the Guidant unit it acquired in 2006 knowingly sold defective heart devices implanted in Medicare patients, the U.S. Justice Department said on Thursday.
Help employers find you! Check out all the jobs and post your resume.